Antimicrobial Agents Practice Questions

Q: Which of the following antibiotics does not contain a beta-lactam ring?

Linezolid. ***Linezolid*** - **Linezolid** is an **oxazolidinone antibiotic**, which has a different chemical structure and mechanism of action compared to beta-lactams. - It works by inhibiting bacterial **protein synthesis** at the ribosomal level, specifically binding to the 23S ribosomal RNA of the 50S subunit. *Penicillin* - **Penicillin** is the prototypic **beta-lactam antibiotic**, characterized by a four-membered beta-lactam ring in its chemical structure [1]. - Its mechanism of action involves inhibiting **bacterial cell wall synthesis** by binding to penicillin-binding proteins (PBPs) [3]. *Cefotaxime* - **Cefotaxime** is a **third-generation cephalosporin**, which belongs to the beta-lactam class of antibiotics [1], [2]. - All cephalosporins, like penicillins, possess a **beta-lactam ring** essential for their antibacterial activity [3]. *Imipenem* - **Imipenem** is a **carbapenem antibiotic**, another class within the beta-lactam family [1]. - Like other beta-lactams, it contains a **beta-lactam ring** and acts by interfering with bacterial **cell wall synthesis** [3].

Q: A patient with a history of penicillin allergy is admitted with bacterial meningitis. After receiving intravenous antibiotics, she develops a severe reaction. Which of the following drugs is most likely responsible for her condition?

Vancomycin. ***Vancomycin*** - **Vancomycin infusion reaction** (formerly "red man syndrome") is a common adverse effect, especially with rapid intravenous administration, characterized by **flushing, rash, pruritus**, and sometimes **hypotension** or **angioedema**. - This reaction results from **non-IgE-mediated mast cell degranulation**, leading to histamine release, and is not directly related to penicillin allergy but can be mistaken for an allergic reaction. *Gentamicin* - Gentamicin is an **aminoglycoside** and is not typically associated with severe immediate hypersensitivity reactions like the one described. - Its main toxicities include **nephrotoxicity** and **ototoxicity**, often occurring with prolonged use or high concentrations. *Chloramphenicol* - Chloramphenicol is associated with serious but less common adverse effects such as **bone marrow suppression** (aplastic anemia) or **grey baby syndrome** in neonates. - It does not commonly cause acute, severe hypersensitivity reactions presenting as a rash and flushing. *Doxycycline* - Doxycycline is a **tetracycline antibiotic** and is generally well-tolerated, though it can cause photosensitivity, gastrointestinal upset, and esophageal irritation. - Like the other incorrect options, it does not typically induce acute, severe infusion reactions mimicking an allergic response in the way vancomycin does, especially in a penicillin-allergic patient.

Q: Which of the following statements regarding pyrazinamide is FALSE?

One should discontinue treatment if hyperuricemia occurs. ***One should discontinue treatment if hyperuricemia occurs*** - While pyrazinamide commonly causes **hyperuricemia** by reducing renal excretion of uric acid, it rarely leads to **gouty arthritis** and is generally not an indication for discontinuing treatment. - Management typically involves symptomatic relief for any occurring gout attacks, rather than stopping the essential antituberculosis medication. *There is minimal cross resistance with INH* - Pyrazinamide and **isoniazid (INH)** have distinct mechanisms of action against *Mycobacterium tuberculosis*. - Resistance to one drug usually does not imply resistance to the other, making them effective combination partners in tuberculosis treatment. *Polyarthralgia is a common side effect* - **Polyarthralgia** is a frequently reported side effect of pyrazinamide, often thought to be related to its effect on uric acid metabolism. - This symptom is usually mild and self-limiting and does not typically require discontinuation of the drug. *It can cause hepatotoxicity* - Pyrazinamide is known to be **hepatotoxic**, and elevated liver enzymes are a common adverse effect. - Regular monitoring of **liver function tests** is recommended during treatment with pyrazinamide, and it may need to be discontinued if significant liver injury occurs.

Q: Pseudojaundice is seen during the treatment with which antituberculous agent?

Rifampicin. ***Rifampicin*** - **Rifampicin (Rifampin)** causes a benign, harmless **pseudojaundice** characterized by **orange-red discoloration of urine, tears, sweat, saliva, and soft contact lenses**. - This is due to the drug's natural **orange-red pigment** and its excretion in body fluids, NOT due to actual liver dysfunction or bilirubin accumulation. - Patients should be warned about this harmless side effect to avoid unnecessary concern. *Rifabutin* - **Rifabutin**, a rifamycin analog, also causes orange-red discoloration of body fluids similar to rifampicin. - However, **rifampicin is the classic drug** most commonly associated with the term "pseudojaundice" in standard pharmacology references. - Rifabutin is used as an alternative to rifampicin in certain situations (e.g., HIV patients on antiretrovirals). *Ethambutol* - **Ethambutol** is known for causing **optic neuritis (retrobulbar neuritis)**, leading to **red-green color blindness** and visual field defects. - It does not cause jaundice or pseudojaundice. *Pyrazinamide* - **Pyrazinamide** is associated with **hepatotoxicity**, which can manifest as elevated liver enzymes and, in severe cases, actual **jaundice** due to liver damage. - It does not cause pseudojaundice, which is a harmless discoloration without liver dysfunction.

Q: Lamivudine belongs to which class of antiretroviral drugs?

Nucleoside reverse transcriptase inhibitor. ***Nucleoside reverse transcriptase inhibitor*** - **Lamivudine** is a synthetic nucleoside analog that competitively inhibits **HIV-1 reverse transcriptase**, incorporating into the viral DNA and leading to chain termination [1]. - As a **nucleoside reverse transcriptase inhibitor (NRTI)**, it requires intracellular phosphorylation to its active triphosphate form [1], [2]. *Nucleotide reverse transcriptase inhibitor* - **Nucleotide reverse transcriptase inhibitors (NtRTIs)** are structurally similar to nucleotides, meaning they already contain a phosphate group [2]. - They tend to have a **higher barrier to resistance** and include drugs like **tenofovir disoproxil fumarate** (TDF) and **tenofovir alafenamide** (TAF). *Non-nucleoside reverse transcriptase inhibitor* - **Non-nucleoside reverse transcriptase inhibitors (NNRTIs)** bind directly to a **hydrophobic pocket** on the reverse transcriptase enzyme, causing a conformational change that inhibits its activity [4]. - Unlike NRTIs/NtRTIs, NNRTIs do not require phosphorylation to be active and do not act as **chain terminators** [1]. *Protease inhibitor* - **Protease inhibitors (PIs)** prevent the HIV protease enzyme from cleaving viral polyproteins into functional proteins, which are essential for the assembly of new infectious virions [3], [4]. - This class of drugs, such as **ritonavir** and **atazanavir**, interferes with the final maturation step of the virus [3].

Q: The combination of trimethoprim and sulfamethoxazole is effective against which of the following opportunistic infections in the AIDS patient?

Pneumocystis jirovecii. ***Pneumocystis jiroveci*** - **Pneumocystis pneumonia (PCP)**, caused by *Pneumocystis jirovecii*, is a common and severe opportunistic infection in AIDS patients. - ** Trimethoprim-sulfamethoxazole (TMP-SMX)**, also known as Bactrim, is the **drug of choice** for both treatment and prophylaxis of PCP [1], [2]. *Disseminated Herpes simplex infection* - **Herpes simplex virus (HSV)** infections are typically treated with antiviral medications like **acyclovir, valacyclovir, or famciclovir**. - TMP-SMX has **no antiviral activity** and is ineffective against HSV. *Cryptococcal meningitis infection* - **Cryptococcal meningitis** is a fungal infection primarily treated with **amphotericin B** in combination with **flucytosine**, followed by fluconazole for maintenance. - TMP-SMX is **not active** against *Cryptococcus neoformans*. *Tuberculosis infection* - **Tuberculosis (TB)**, caused by *Mycobacterium tuberculosis*, requires a **multi-drug regimen** typically including isoniazid, rifampin, pyrazinamide, and ethambutol [3]. - While TMP-SMX has some activity against *Nocardia spp.* and some atypical mycobacteria, it is **not effective** for the treatment of *Mycobacterium tuberculosis*.

Q: All of the following are sulphonamides used topically except.

Sulphadiazine. ***Sulphadiazine*** - **Sulphadiazine** itself is primarily used for **systemic infections** such as toxoplasmosis, often in combination with pyrimethamine. - While it is a **sulfonamide**, it is not formulated for **topical application** in its uncombined form. *Sulphacetamide* - **Sulphacetamide** is commonly used as an **ophthalmic solution** or ointment to treat bacterial **conjunctivitis** and other eye infections. - It is well-suited for **topical application** due to its good tissue penetration and antimicrobial activity against common eye pathogens. *Silver sulphadiazine* - **Silver sulphadiazine** is a widely used **topical cream** for the prevention and treatment of **burn wound infections**. - The combination of **silver ions** and sulphadiazine provides broad-spectrum **antimicrobial activity** against bacteria and fungi in open wounds. *Mafenide* - **Mafenide** is a powerful **topical sulfonamide** primarily used to prevent and treat bacterial **infections in burns**. - It is known for its ability to penetrate **eschar** (necrotic tissue) effectively, making it valuable in deep burn wound management.

Q: Which of the following drugs is useful in the prophylaxis of meningococcal meningitis?

Rifampin. ***Rifampin*** - **Rifampin** is the **first-line agent** for **chemoprophylaxis** of meningococcal meningitis according to CDC guidelines. - Administered as **600 mg twice daily for 2 days** (adults) or **10 mg/kg twice daily for 2 days** (children). - Works by inhibiting bacterial RNA polymerase, achieving excellent penetration into respiratory secretions to eliminate nasopharyngeal carriage of **Neisseria meningitidis**. - Recommended for close contacts of index cases to prevent secondary transmission. *Doxycycline* - **Doxycycline** is **not recommended** for meningococcal prophylaxis in current guidelines. - While it has some activity against Neisseria meningitidis, it is not included in CDC or WHO recommendations due to inconsistent efficacy and the availability of more effective alternatives. - Tetracyclines are not first-line agents for this indication. *Minocycline* - **Minocycline** was historically used for meningococcal prophylaxis but is **no longer recommended**. - Significant side effects including **vertigo, dizziness**, and **ataxia** limit its use. - It has been replaced by safer and more effective alternatives like rifampin and ciprofloxacin. *Cephalexin* - **Cephalexin** is a first-generation cephalosporin used primarily for **skin, soft tissue**, and some **urinary tract infections**. - It is **not effective** against **Neisseria meningitidis** and has **no role** in meningococcal meningitis prophylaxis. - Note: **Ceftriaxone** (third-generation cephalosporin) is an alternative for prophylaxis, but cephalexin is not.

Q: Which of the following antibiotics is the drug of choice for Gram-negative anaerobes?

Metronidazole. ***Metronidazole*** - **Metronidazole** is highly effective against most **Gram-negative anaerobic bacteria**, including *Bacteroides fragilis*, a common pathogen in intra-abdominal infections and abscesses. - It works by forming **nitro-radicals** that damage microbial DNA, exhibiting potent **bactericidal action** against anaerobes. *Aztreonam* - **Aztreonam** is a **monobactam** antibiotic with a narrow spectrum of activity, primarily targeting **Gram-negative aerobic bacteria** (e.g., *Pseudomonas aeruginosa*). - It is **inactive against Gram-positive bacteria** and **anaerobes**, making it unsuitable for Gram-negative anaerobic infections. *Doxycycline* - **Doxycycline** is a **tetracycline antibiotic** with broad-spectrum activity against many Gram-positive and Gram-negative **aerobic** and some anaerobic organisms. - While it has some anaerobic activity, it is **not the drug of choice for significant Gram-negative anaerobic infections** due to resistance patterns and the superior efficacy of metronidazole. *Vancomycin* - **Vancomycin** is primarily used for **Gram-positive bacterial infections**, especially those resistant to other antibiotics like methicillin-resistant *Staphylococcus aureus* (**MRSA**). - It has **no activity against Gram-negative bacteria**, **aerobic or anaerobic**, as its large molecular size prevents penetration of the outer membrane.

Q: Second-generation cephalosporin that can be used orally is:

Cefaclor. ***Cefaclor*** - **Cefaclor** is a commonly used **second-generation cephalosporin** that is available in an **oral formulation**, making it suitable for outpatient treatment of various bacterial infections. - Its spectrum of activity includes many Gram-positive and Gram-negative bacteria, often used for **respiratory tract infections** and **otitis media**. *Cefepime* - **Cefepime** is a **fourth-generation cephalosporin**, not a second-generation one, and is primarily administered **intravenously** for severe infections. - It has a broader spectrum against both Gram-positive and Gram-negative bacteria, including **Pseudomonas aeruginosa**. *Cefalothin* - **Cefalothin** (also known as cephalothin) is a **first-generation cephalosporin** that is typically administered **parenterally** (intravenously or intramuscularly). - It is not available in an oral formulation, limiting its use to hospital settings for moderate to severe infections. *Cefadroxil* - **Cefadroxil** is a **first-generation cephalosporin** and is available for oral administration. - While it is an oral cephalosporin, it belongs to the first generation, not the second generation as requested by the question.

Question 1

Which of the following antibiotics does not contain a beta-lactam ring?

Accepted Answer

Linezolid

Answer

Penicillin

Answer

Cefotaxime

Answer

Imipenem

Question 2

A patient with a history of penicillin allergy is admitted with bacterial meningitis. After receiving intravenous antibiotics, she develops a severe reaction. Which of the following drugs is most likely responsible for her condition?

Accepted Answer

Vancomycin

Answer

Chloramphenicol

Answer

Gentamicin

Answer

Doxycycline

Question 3

Which of the following statements regarding pyrazinamide is FALSE?

Accepted Answer

One should discontinue treatment if hyperuricemia occurs

Answer

It can cause hepatotoxicity

Answer

There is minimal cross resistance with INH

Answer

Polyarthralgia is a common side effect

Question 4

Pseudojaundice is seen during the treatment with which antituberculous agent?

Accepted Answer

Rifampicin

Answer

Ethambutol

Answer

Pyrazinamide

Answer

Rifabutin

Question 5

Lamivudine belongs to which class of antiretroviral drugs?

Accepted Answer

Nucleoside reverse transcriptase inhibitor

Answer

Nucleotide reverse transcriptase inhibitor

Answer

Non-nucleoside reverse transcriptase inhibitor

Answer

Protease inhibitor

Question 6

The combination of trimethoprim and sulfamethoxazole is effective against which of the following opportunistic infections in the AIDS patient?

Accepted Answer

Pneumocystis jirovecii

Answer

Disseminated Herpes simplex infection

Answer

Cryptococcal meningitis infection

Answer

Tuberculosis infection

Question 7

All of the following are sulphonamides used topically except.

Accepted Answer

Sulphadiazine

Answer

Silver sulphadiazine

Answer

Mafenide

Answer

Sulphacetamide

Question 8

Which of the following drugs is useful in the prophylaxis of meningococcal meningitis?

Accepted Answer

Rifampin

Answer

Doxycycline

Answer

Minocycline

Answer

Cephalexin

Question 9

Which of the following antibiotics is the drug of choice for Gram-negative anaerobes?

Accepted Answer

Metronidazole

Answer

Vancomycin

Answer

Aztreonam

Answer

Doxycycline

Question 10

Second-generation cephalosporin that can be used orally is:

Accepted Answer

Cefaclor

Answer

Cefepime

Answer

Cefalothin

Answer

Cefadroxil

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?